arrow
X

Xiaozeng Wang

General Hospital of Northern Theater Command
H指数:19
被引数:1,641

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Comparison of clopidogrel monotherapy versus prolonged DAPT based on the GRACE score in patients with acute coronary syndromes at High Ischemic and Bleeding Risk: a subgroup analysis of the OPT-BIRISK randomized clinical trial” [Eur. J. Pharmacol. 1006 5 (2025) 178151]

勘误:“基于GRACE评分的高缺血和出血风险急性冠状动脉综合征患者氯吡格雷单药治疗与延长DAPT的对比:OPT-BIRISK随机临床试验的亚组分析”[Eur. J. Pharmacol. 1006 5 (2025) 178151]

2025-10-100
OAAI
Comparison of clopidogrel monotherapy versus prolonged DAPT based on the GRACE risk score in patients with acute coronary syndromes at high ischemic and bleeding risk: a subgroup analysis of the OPT-BIRISK randomized clinical trial

基于GRACE风险评分对急性冠状动脉综合征高缺血和高出血风险患者中氯吡格雷单药治疗与延长DAPT的对比:OPT-BIRISK随机临床试验的亚组分析

2025-09-130
PREAI
Effect of high sensitivity C-reactive protein on uric acid-related cardiometabolic risk in patients with coronary artery disease-a large multicenter prospective study

高敏C反应蛋白对冠心病患者尿酸相关心血管代谢风险的影响 -- 一项大型多中心前瞻性研究

2024-11-260
OAAI
The combined effect of triglyceride-glucose index and high-sensitivity C-reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study

甘油三酯-葡萄糖指数和高敏C反应蛋白对慢性冠脉综合征患者心血管结局的联合影响: 一项多中心队列研究

2024-08-131
OA
Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia
2023-07-241
OAAI